Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Aggarwal

Showing results (241-250 of 280) with videos related to

Pageof 28
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 15, 2023
A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancerChristian D Fankhauser, Matthew G Parry, Adnan Ali, et al.
Plos One|April 28, 2020
The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaborationAjay Aggarwal, Preeti Patel, Grant Lewison, et al.
JAMA Network Open|August 18, 2022
Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income CountriesFidel Rubagumya, Wilma M Hopman, Bishal Gyawali, et al.
Journal of Applied Clinical Medical Physics|November 22, 2022
Customizable landmark-based field aperture design for automated whole-brain radiotherapy treatment planningYao Xiao, Carlos Cardenas, Dong Joo Rhee, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2022
Is Clinical Research Serving the Needs of the Global Cancer Burden? An Analysis of Contemporary Global Radiation Therapy Randomized Controlled TrialsJoanna Dodkins, Wilma M Hopman, John Connor Wells, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 25, 2019
The management impact of <sup>68</sup>gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (<sup>68</sup>Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancerMeghana Kulkarni, Simon Hughes, Andrew Mallia, et al.
BJU International|February 18, 2026
Characteristics and outcomes of men presenting with complications of metastatic prostate cancerArjun Nathan, Matthew G Parry, Adrian Cook, et al.
Prostate Cancer and Prostatic Diseases|January 10, 2022
Comparison of the treatment of men with prostate cancer between the US and England: an international population-based studyMatthew G Parry, Julie Nossiter, Melanie Morris, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2018
Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planningMursheda Begum, Grant Lewison, Jacek Jassem, et al.
The Lancet. Oncology|April 30, 2021
Cancer and COVID-19 vaccines: a complex global pictureAasim Yusuf, Diana Sarfati, Christopher M Booth, et al.
Pageof 28

Showing results (241-250 of 280) with videos related to

Sort By:
Pageof 28
European Journal of Cancer (Oxford, England : 1990)|January 15, 2023
A low prostate specific antigen predicts a worse outcome in high but not in low/intermediate-grade prostate cancerChristian D Fankhauser, Matthew G Parry, Adnan Ali, et al.
Plos One|April 28, 2020
The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaborationAjay Aggarwal, Preeti Patel, Grant Lewison, et al.
JAMA Network Open|August 18, 2022
Participation of Lower and Upper Middle-Income Countries in Clinical Trials Led by High-Income CountriesFidel Rubagumya, Wilma M Hopman, Bishal Gyawali, et al.
Journal of Applied Clinical Medical Physics|November 22, 2022
Customizable landmark-based field aperture design for automated whole-brain radiotherapy treatment planningYao Xiao, Carlos Cardenas, Dong Joo Rhee, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2022
Is Clinical Research Serving the Needs of the Global Cancer Burden? An Analysis of Contemporary Global Radiation Therapy Randomized Controlled TrialsJoanna Dodkins, Wilma M Hopman, John Connor Wells, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 25, 2019
The management impact of <sup>68</sup>gallium-tris(hydroxypyridinone) prostate-specific membrane antigen (<sup>68</sup>Ga-THP-PSMA) PET-CT imaging for high-risk and biochemically recurrent prostate cancerMeghana Kulkarni, Simon Hughes, Andrew Mallia, et al.
BJU International|February 18, 2026
Characteristics and outcomes of men presenting with complications of metastatic prostate cancerArjun Nathan, Matthew G Parry, Adrian Cook, et al.
Prostate Cancer and Prostatic Diseases|January 10, 2022
Comparison of the treatment of men with prostate cancer between the US and England: an international population-based studyMatthew G Parry, Julie Nossiter, Melanie Morris, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2018
Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planningMursheda Begum, Grant Lewison, Jacek Jassem, et al.
The Lancet. Oncology|April 30, 2021
Cancer and COVID-19 vaccines: a complex global pictureAasim Yusuf, Diana Sarfati, Christopher M Booth, et al.
Pageof 28